| SR. NO. | Day 1 – Sunday, November 17 | Day 2 – Monday, November 18 | Day 3 – Tuesday, November 19 |
|---|---|---|---|
| 1 | IPF SESSION I Chairs: Alberto Caggiati, Antonios Gasparis |
IPF SESSION II Chair: Ashkan Haghshenas, Malay Patel |
SCIENTIFIC SESSION: Complications and failures in phlebological treatment Chair: Alun H Davies |
| 2 | Dr. Graciela Figueiredo 8.00-8.10 Presidential Lecture |
Dr. Enrico Cappello, Dr. Grzegorz Halena IPF Consensus Report – Contraindications to Sclerotherapy |
Dr. Victor Canata Underuse, overuse or misuse of the phlebological treatment? – treatment overuse or insufficiently trained operators |
| 3 | Dr. Oscar Bottini 8.10-8.20 IPF Future: Our Vision and Mission |
Dr. Tobias Hirsch, Dr. Mabel Bussati IPF Consensus Report – Pelvic Venous Insufficiency |
Dr. Steve Elias Matting is the issue – how to avoid and treat? |
| 4 | Dr. Marianne de Maeseneer 8.20 – 8.30 IPF Scientific Committee. Major Scientific Findings in Phlebology in the Past 2 Years |
Dr. Louay Altarazi, Dr. Jawed Fareed IPF Consensus Report – Venous Mapping |
Hyperpigmentation after vein treatment Eberhard Rabe Dermatologists point of view |
| 5 | Dr. Guillermo Camicia 8.30 – 8.40 Post-thrombotic Syndrome: Need for a New Instrument |
Dr. Niels Bækgaard IPF Consensus Report – Venous Rehabilitation |
Hyperpigmentation after vein treatment Dr. Larisa Chernukha Phlebologists point of view |
| 6 | Dr. Kathleen Gibson 8.40 – 8.45 IPF Operations: Need for Reform |
Dr. Denis Borsuk, Dr. Alun H Davies Pan-American Consensus on Ultrasound-guided Foam Sclerotherapy |
Dr. Malay Patel Visual and Neurological complications of sclerotherapy |
| 7 | Dr. Devendra B Dekiwadia 8.45 – 8.55 IPF Education Program: Our exciting new initiatives |
IPF Bauerfeind Award Presentation Dr. Grzegorz Halena, Dr. Steve Elias Influence of compression treatment in patients with Pelvic Congestion Syndrome |
Dr. Rodrigo Bono Fukushima EHIT and ostial thrombotic complications after saphenous ablation – do we need routinely follow up the patients with US? |
| 8 | Dr. Oscar Bottini 8.55 – 9.00 IPF Educational Modules |
IPF Servier Award Presentation Dr. Tobias Hirsch The Athlete’s Vein: Venous Adaptations of the Lower Limb in Endurance Athletes |
Alessandro Frullini A multicentric study on the role of heparin prophylaxis of thrombotic complications in foam sclerotherapy (the Prosclep study) |
| 9 | IPF Vice Presidents: Dr. Denis Borsuk, Dr. Devendra B Dekiwadia, Dr Malay Patel, Dr. Ravul Jindal 9.00 – 9.20 Around the Globe with IPF: North America, Latin America, Northern Europe, Near East, North Africa, Southern Europe, Asia and Oceania |
IPF Kreussler Award Presentation Dr. Alberto Caggiati Reducing Hyperpigmentation After Sclerotherapy using an antithrombotic drug: (RHyAS) trial Midterm results |
Frantisek Zernovicky NTNT ablation complications can happen – how to deal with it? |
| 10 | Discussion 9.20 – 9.30 |
Discussion | Dr. Antonios Gasparis Granuloma formtion as a long term complication of glue |
| 11 | KEYNOTE LECTURE: Mark Meissner 9.35 – 09.55 Chronic pelvic vein disease 2019 update: what do we know? what we do not know? |
KEYNOTE LECTURE: Alfred Obermayer From understanding chronic venous ulceration to effective treatment |
Discussion |
| 12 | Coffee break 10.00 – 10.30 |
Coffee break | Coffee break |
| 13 | SCIENTIFIC SESSION: Foam Sclerotherapy – from the consensus document to the clinical practice 10.30 – 12.00 Chair: Dr. Ravul Jindal |
SCIENTIFIC SESSION: Post-thrombotic syndrome – towards consensus on definition, scoring and effective preventionChair: M. MeissnerCo-moderators: Dr. Jawed Fareed, Dr. Victor Canata |
SCIENTIFIC SESSION: Focus on varicose vein recurrenceChair: M. de MaeseneerCo-moderators: M. Meissner, A. Mumme, F. Pannier, U. Maurins, Dong-ik Kim, T. Urbanek |
| 14 | Dr. Tobias Hirsch 10.30 – 10.40 New European Guidelines on Sclerotherapy – what is new? |
Mark Meissner What is post-thrombotic syndrome and how we measure this? |
Marlin Schul Does the choice of the treatment method decrease the recurrence rate? |
| 15 | Alberto Caggiati 10.40 – 10.55 Tips and tricks of successfully maintaining and injecting foam – what should we know about US guided foam sclerotherapy? |
Alun H Davies Secondary chronic venous disease – the role of reflux and obstruction |
Antonios Gasparis Standard for the investigation of the saphenous terminal and preterminal valve on duplex |
| 16 | Ashkan Haghshenas 10.55 – 11.05 Foam sclerotherapy – the safety issue |
Dr Denis Borsuk Management of the post-thrombotic syndrome – lessons learned |
Dr Devendra B Dekiwadia Alarmingly high rates of groin recurrence following endovenous laser therapy |
| 17 | Dr Malay Patel 11.05 – 11.15 Saphenous vein sclerotherapy – does tumescence and blood irrigation make the difference? |
Dr. Luiz Fernando Albernaz PTS predictive factors – what do we know about? |
Dr. Ravul Jindal Reflux sources after surgical treatment and endovenous ablation: does accessory saphenous, big tributaries and perforator closure really work in the varicose vein recurrence prevention? |
| 18 | Enrico Cappello 11.15 – 11.25 Foam Sclerotherapy in C1 treatment |
Graciela Figueiredo Does the compression and early mobilization work in PTS prevention? |
Grzegorz Halena Primary saphenous stump closure – lessons learned from “0 level“ saphenous ostial ablation |
| 19 | Guillermo Camicia 11.25 – 11.35 How sclerothepary can replace phlebectomy in primary therapeutic attempt or in the recurrent varicose vein treatment? |
Jawed Fareed Does thrombolysis work in PTS prevention? – recent RC trial results: Attract trial data |
Kathleen Gibson What do we need: better technology or better strategy? Varicose veins after saphenous ablation and surgery: disease recurrence or disease progression? |
| 20 | Larisa Chernukha 11.35 – 11.45 Is atrophie blanche irreversible? Effects of foam sclerotherapy |
Louay Altarazi The Effect of Successful Ultrasound-Accelerated Catheter-Directed Thrombolysis on Preventing Post-Thrombotic Syndrome – CAVA trial subgroup analysis |
Mabel Bussati Varicose vein surgery in postthrombotic limb |
| 21 | Marianne de Maeseneer 11.45 – 11.55 Foam sclerotherapy – lessons from physics and chemistry |
Niels Bækgaard Does anticoagulation works in PTS prevention? |
Oscar Bottini Long term (20 years) results of preventive and venopreserving operations |
| 22 | Session summary: Rodrigo Bono Fukushima 11.55 – 12.00 Discussion will continue during the LUNCH with the Sclerotherapy Experts – Multi Hall S4 12.00-12.45 |
Discussion: PTS definition, criteria and assessment have to be updated | Session summary Discussion will continue during the LUNCH with the Experts – Multi Hall S4 12.05-13.00 |
| 23 | Lunch 12.00 – 13.00 |
Lunch Discussion with PTS Experts – Exhibition Area/Discussion Corner 12.00-12.40 Discussion moderator: M. Meissner Experts: P. Prandoni, A. Davies, N. Baekgaard, A. Gasparis, S. Black, M. Lichtenberg, S. Gianesini, T. Urbanek, C. Wittens, Z. Krasiński, N. Labropoulos, M. de Maessener, H. Bjarnason, S. Elias, L. Kabnick, T. Hirsch, E. Shaydakov, Z. Lazarashvili |
Lunch |
| 24 | SCIENTIFIC SESSION: C0s – towards consensus on the diagnostics and therapy 13.00 – 14.15 Chair: A. NicolaidesCo-moderators: E. Rabe, N. Labropoulos, C. Allegra, S. Kakkos, M. Schul , A. Jawień |
SCIENTIFIC SESSION: Truncal varicose veins – therapeutic opportunity updateChair: N. LabropoulosCo-moderators: N. Morrison, A. Mumme, U. Maurins, M. Schul, L. Moraglia, A. Zielinski |
INDUSTRY SUPPORTED SESSION Compression treatment in Phlebology and Lymphology: today and in the future Session supported by MEDIChair: N. Morrison, E. Rabe |
| 25 | Steve Elias 13.00 – 13.10 Epidemiology of C0s – what do we know about? |
Tobias Hirsch Patient presentation and examination – truncal varicose veins VS at UIP Krakow 2019 |
Victor Canata Post-thrombotic syndrome: why do we need compression? |
| 26 | Alberto Caggiati 13.10 – 13.20 The link between hemodynamics and signs as well as symptoms of the chronic venous disease |
Alun H Davies Update of technology and results for thermal ablation |
Antonios Gasparis Adjustable velcro devices: the future gold-standard treatment in venous ulcer? |
| 27 | Ashkan Haghshenas 13.20 – 13.30 Symptoms of the chronic venous disease learning through a clinical casev. How to assess the symptoms of the chronic venous disease – 2019 update? |
Dr Denis Borsuk Update of technology and results for thermal ablation |
Dr Devendra B Dekiwadia Compression, well-being and PNEI (Psychoneuroendocrineimmunology) |
| 28 | Dr Malay Patel 13.30 – 13.40 Chronic venous disease progression – is it unavoidable? |
Dr. Luiz Fernando Albernaz Update of technology and results for non-thermal ablation |
Dr. Ravul Jindal Treating skin inflammation with compression |
| 29 | Enrico Cappello 13.40 – 13.50 C0s diagnostics – objective evaluation and possibilities of confirmation of the chronic disease presence in C0s patients |
Graciela Figueiredo Achim Mumme Surgical stripping is still in the game! |
Discussion |
| 30 | Grzegorz Halena 13.50 – 14.00 C0s treatment possibilities – 2019 update |
Truncal varicose vein surgical treatment Sergio Gianesini Saphenous vein sparing surgery: when, how and how long does it last? |
SCIENTIFIC SESSION: Research from the world – awarded abstracts session (7 min presentations + 3 min discussions)Chair: K. Parsi, C. Allegra |
| 31 | Discussion 14.00 – 14.15 |
Guillermo Camicia An overview of the RCT on the truncal VV treatment – do we know which method is best one? |
Thodur Vasudevan, Ramon L. Varcoe, David A. Robinson, Andrew A. Hill, Andrew Holden, Odette Hart Initial Results Of A First-In-Man Clinical Trial For Endovenous Deep Venous Valve Formation To Treat Chronic Venous Insufficiency |
| 32 | SCIENTIFIC SESSION: Innovations in phlebology 14.15 – 15.30 Chair: S. EliasCo-moderators: R. Milleret, Ch. Ragg, W. Chi, T. Yamaki, E. Shaydakov, G. Halena |
The problems in truncal varicose vein treatment Marlin Schul Options for large diameter saphenous vein |
Huw Davies, Mike Watkins, Gareth Bate, Tracy Ellis, Andrew Bradbury Neurological Events Following Ultrasound Guided Foam Sclerotherapy Using Sodium 5. Tetradecyl Sulphate (Fibrovein) |
| 33 | Jawed Fareed 14.15 – 14.25 Fully percutaneously created or surgically inserted artificial vein valves in CVD treatment – research status and first clinical data |
Simultaneous or staged varicose vein treatment after saphenous ablation Debate: Staged treatment brings benefits Uldis Maurins For the motion |
Kathleen Gibson Relationship Between Medical Compression And Intramuscular Pressure As An Explanation Of A Compression Paradox |
| 34 | Larisa Chernukha 14.25 – 14.35 Recent developments in the dedicated venous stents – lessons learned and future direction |
Simultaneous or staged varicose vein treatment after saphenous ablation Debate: Staged treatment brings benefits Alun Davies Against the motion |
Louay Altarazi Relationship Of Reflux Patterns To Health-Related Quality Of Life And Clinical Severity Scores |
| 35 | Mabel Bussati 14.35 – 14.45 Hyaluronan injection based treatment in phlebology – why and when? |
Marianne de Maeseneer “Choose wisely” – chemical or thermal ablation in the treatment of the incompetent saphenous vein (the French proposal) |
Niels Bækgaard Egyptian Experience In Venous Ulcer Abolishing Most Distal Reflux: Does It Count? |
| 36 | Oscar Bottini 14.45 – 14.55 First percutaneous – non invasive – vein ablations using high intensity focused ultrasound (HIFU) |
Rodrigo Bono Fukushima What the new German guidelines on varicose vein treatment say? |
Session Summary: Steve Elias |
| 37 | Tobias Hirsch 14.55 – 15.05 Transcutaneous obliteration of varicose veins by ultrasound: HIFU and Cavitation solutions |
Victor Canata Does the choice of the method really matters for truncal varicose veins treatment? |
Coffee break |
| 38 | Alberto Caggiati 15.05 – 15.15 Telemetric vein diagnostics: how does technology enable patients compliance? |
Alun H Davies Superficial chronic venous disease: from HOW to WHAT and WHY to treat |
SCIENTIFIC SESSION: C1 Treatment updateChair: A. Cavezzi |
| 39 | Antonios Gasparis 15.15 – 15.25 SFALT: Sclerofoam assisted laser therapy for saphenous refluxes: an innovative tumescence-free technique |
Jaroslav Strejček, Michael Schubert Endovenous laser ablation with 1940 nm, new direction or blind street? |
Ashkan Haghshenas C1 pathology or another disease – be careful! |
| 40 | Session summary: Dr Denis Borsuk 15.25 – 15.30 Discussion with the Innovators – Exhibition Area/Discussion Corner |
Discussion | Dr Devendra B Dekiwadia How to optimize the small vein chemical ablation – liquid or foam ?! |
| 41 | Coffee break 15.30 – 16.00 |
Coffee break | Dr Malay Patel C1 sclerotherapy – state of art |
| 42 | SCIENTIFIC SESSION: What is new in our understanding of the chronic venous disease 16.00 – 17.35 Chair: A. NicolaidesCo-moderators: N. Morrison, C. Allegra, P. Thibault, Ch. Lattimer, T. Zubilewcz, S. Kakkos |
SCIENTIFIC SESSION: Great Venous Leg Ulcer Forum – conservative or aggressive approach in post – EVRA eraChair: D. HeimCo-moderators: G. Mosti, A. Davies, G M. Malouf, A. Obermayer, W. Taha, A. Jawień |
Dr. Luiz Fernando Albernaz Compression following sclerotherapy of C1 varicose veins – necessary or not? Results of the SklerKomp Study |
| 43 | Dr. Ravul Jindal 16.00 – 16.10 Our current understanding of the chronic venous obstruction |
Enrico Cappello Venous leg ulcer treatment – do we really have consensus? /summary of the existing guidelines/ |
Graciela Figueiredo Virtual reality sclerotherapy – the tool for better results |
| 44 | Grzegorz Halena 16.10 – 16.20 Chronic venous thrombosis – does it really exsist |
Guillermo Camicia Global management of the venous leg ulcer in the pre EVRA era |
Jawed Fareed CLaCS (Cryo-Laser and Cryo-Sclerotherapy) in C1 Patients IMAP at UIP Krakow 2019 |
| 45 | Kathleen Gibson 16.20 – 16.30 What is new in our understanding of the cerebral venous outflow? – possible link with neurodegeneration |
Larisa Chernukha No ulcer treatment without hemodynamic analysis! |
Louay Altarazi SCORE 9-1: instructions for users and clinical application IMAP at UIP Krakow 2019 |
| 46 | Mabel Bussati 16.30 – 16.40 Neck vein obstruction: Diagnosis and the role of chronic Chlamydophila pneumoniae infection |
Marianne de Maeseneer Which compression in the venous leg ulcer patients? – practical advices |
Niels Bækgaard Transdermal laser for varicose veins from physics to practice |
| 47 | Oscar Bottini 16.40 – 16.50 Every valve tells a story! what do we know from HR Ultrasound research on the valve impact on the CVD occurrence and progression – clinical implications |
Rodrigo Bono Fukushima Venous leg ulcer treatment – does pharmacotherapy matter? |
Steve Elias Best standards in the use of transdermal laser in the treatment of the reticular veins and telangiectasias |
| 48 | Tobias Hirsch 16.50 – 17.00 Venous diameter, clinical severity and quality of life – does the size of the incompetent vein matters? |
Dr Ravul Jindal EVRA trial – early invasive reflux ablation brings benefits to the VLU leg ulcer patients |
Dr Ravul Jindal What is new in the transcutaneous laser treatment of the C1 pathology and complication treatment |
| 49 | Alun H Davies 17.00 – 17.10 What is new in our understanding of the chronic venous disease pathogenesis at the cell and tissue level |
Antonios Gasparis Venous Disease, Ulcer Pathophysiology and Novel Treatments |
Ashkan Haghshenas Association between transdermal laser and polidocanol foam. Advantages and disadvantages |
| 50 | Dr Denis Borsuk 17.10 – 17.20 Obesity and Inflammation in venous and lymphatic diseases |
Dr Devendra B Dekiwadia The role of the reflux sourcing and ablation in the venous leg ulcer treatment |
Discussion |
| 51 | Dr Malay Patel 17.20 – 17.25 Guidelines from the world: 5 minutes for 5 emergent recommendations |
Dr. Luiz Fernando Albernaz Aggressive local venous leg ulcer treatment – does it help? |
|
| 52 | Discussion 17.25 – 17.35 Session Summary: Dr. Ravul Jindal |
Enrico Cappello Combined and simultaneous reflux ablation and local surgical treatment – lessons learned |
|
| 53 | Graciela Figueiredo Update of the negative wound pressure therapy for the venous leg ulcer |
||
| 54 | Grzegorz Halena Venous leg ulcer treatment based on the chronic venous disease pathophysiology – lessons learned |
||
| 55 | Guillermo Camicia 1 year outcomes of Venaseal Glue ablation in diabetics with Venous leg ulcer |
||
| 56 | Jawed Fareed Topical Sevoflurane As A New Treatment Modality For Painful Venous Leg Ulcers |
||
| 57 | Discussion | ||
| 58 | Discussion 17.25 – 17.35 Session Summary: Kathleen Gibson |
Larisa Chernukha Combined and simultaneous reflux ablation and local surgical treatment – lessons learned |
|
| 59 | Discussion 17.25 – 17.35 Session Summary: Louay Altarazi |
Mabel Bussati Combined and simultaneous reflux ablation and local surgical treatment – lessons learned |